new_0222_0389|GLSI|Short Name|0|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|sga_expense|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|short_interest|forward_pe_ratio|forward_pe_ratio_1y|forward_ps_ratio|forward_ps_ratio_1y|quarterly_eps_estimates|quarterly_sales_estimates|quarterly_eps_surprise|quarterly_sales_surprise|quarterly_eps_actual|quarterly_sales_actual|sales_est_0y|sales_est_1y|price_target|consensus_recommendation|price_target_num_est|eps_est_0y|eps_est_1y|r_and_d_expense|reconciled_depreciation|interest_expense_non_operating|land_and_improvements|buildings_and_improvements|other_properties|machinery_furniture_equipment
new_0222_0389|GLSI|Long Name|1|1|Greenwich LifeSciences Inc Total Current Assets (Quarterly) (USD)|Greenwich LifeSciences Inc Cash and Short Term Investments (Quarterly) (USD)|Greenwich LifeSciences Inc Inventories (Quarterly) (USD)|Greenwich LifeSciences Inc Net PP&E (Quarterly) (USD)|Greenwich LifeSciences Inc Goodwill and Intangibles (Quarterly) (USD)|Greenwich LifeSciences Inc Total Liabilities (Quarterly) (USD)|Greenwich LifeSciences Inc Total Current Liabilities (Quarterly) (USD)|Greenwich LifeSciences Inc Total Long Term Liabilities (Quarterly) (USD)|Greenwich LifeSciences Inc Total Deposits (Quarterly) (USD)|Greenwich LifeSciences Inc Book Value (Quarterly) (USD)|Greenwich LifeSciences Inc Retained Earnings (Quarterly) (USD)|Greenwich LifeSciences Inc Treasury Stock (Quarterly) (USD)|Greenwich LifeSciences Inc EV to Revenues|Greenwich LifeSciences Inc EV to Earnings|Greenwich LifeSciences Inc EV to Free Cash Flow|Greenwich LifeSciences Inc EV to Assets (Quarterly)|Greenwich LifeSciences Inc PS Ratio|Greenwich LifeSciences Inc PE Ratio|Greenwich LifeSciences Inc Price to Book Value|Greenwich LifeSciences Inc PEG Ratio|Greenwich LifeSciences Inc Debt to Equity Ratio|Greenwich LifeSciences Inc Dividend Yield|Greenwich LifeSciences Inc Shareholder Yield (TTM)|Greenwich LifeSciences Inc Percent of Shares Outstanding Short|Greenwich LifeSciences Inc Total Receivables (Quarterly) (USD)|Greenwich LifeSciences Inc Total Payables (Quarterly) (USD)|Greenwich LifeSciences Inc Total Capital Stock (Quarterly) (USD)|Greenwich LifeSciences Inc Return on Invested Capital|Greenwich LifeSciences Inc Quality Ratio Score|Greenwich LifeSciences Inc Momentum Score|Greenwich LifeSciences Inc Beta (1Y)|Greenwich LifeSciences Inc Sustainable Growth Rate (TTM)|Greenwich LifeSciences Inc Institutional Investor Ownership Percentage|Greenwich LifeSciences Inc Average Diluted Shares Outstanding (Quarterly)|Greenwich LifeSciences Inc Total Employees (Annual)|Greenwich LifeSciences Inc EPS Diluted (Quarterly) (USD)|Greenwich LifeSciences Inc SG&A Expense (Quarterly) (USD)|Greenwich LifeSciences Inc Shares Outstanding|Greenwich LifeSciences Inc Repurchase of Capital Stock (Quarterly) (USD)|Greenwich LifeSciences Inc Ordinary Shares Number (Quarterly)|Greenwich LifeSciences Inc Payout Ratio|Greenwich LifeSciences Inc Quick Ratio (Quarterly)|Greenwich LifeSciences Inc Normalized Diluted EPS (Quarterly) (USD)|Greenwich LifeSciences Inc Stock Buybacks (Quarterly) (USD)|Greenwich LifeSciences Inc Effective Tax Rate (TTM)|Greenwich LifeSciences Inc Return on Equity|Greenwich LifeSciences Inc Net Income (TTM) (USD)|Greenwich LifeSciences Inc Revenue (TTM) (USD)|Greenwich LifeSciences Inc Dividend Per Share (Quarterly) (USD)|Greenwich LifeSciences Inc Revenue (Quarterly) (USD)|Greenwich LifeSciences Inc Gross Profit (Quarterly) (USD)|Greenwich LifeSciences Inc Pre-Tax Income (Quarterly) (USD)|Greenwich LifeSciences Inc Net Income (Quarterly) (USD)|Greenwich LifeSciences Inc Net Interest Income (Quarterly) (USD)|Greenwich LifeSciences Inc Price (USD)|Greenwich LifeSciences Inc Total Return Price (USD)|Greenwich LifeSciences Inc Enterprise Value (USD)|Greenwich LifeSciences Inc 30-Day Average Daily Volume|Greenwich LifeSciences Inc 1 Year Price Returns (Daily)|Greenwich LifeSciences Inc Short Interest|Greenwich LifeSciences Inc PE Ratio (Forward)|Greenwich LifeSciences Inc PE Ratio (Forward 1y)|Greenwich LifeSciences Inc PS Ratio (Forward)|Greenwich LifeSciences Inc PS Ratio (Forward 1y)|Greenwich LifeSciences Inc Quarterly EPS Estimates (USD)|Greenwich LifeSciences Inc Quarterly Revenue Estimates (USD)|Greenwich LifeSciences Inc Quarterly EPS Surprise|Greenwich LifeSciences Inc Quarterly Revenue Surprise|Greenwich LifeSciences Inc Quarterly Actual EPS (USD)|Greenwich LifeSciences Inc Quarterly Actual Revenue (USD)|Greenwich LifeSciences Inc Revenue Estimates for Current Fiscal Year (USD)|Greenwich LifeSciences Inc Revenue Estimates for Next Fiscal Year (USD)|Greenwich LifeSciences Inc Price Target (USD)|Greenwich LifeSciences Inc Consensus Recommendation|Greenwich LifeSciences Inc Price Target Num Estimates|Greenwich LifeSciences Inc EPS Estimates for Current Fiscal Year (USD)|Greenwich LifeSciences Inc EPS Estimates for Next Fiscal Year (USD)|Greenwich LifeSciences Inc Research and Development Expense (Quarterly) (USD)|Greenwich LifeSciences Inc Reconciled Depreciation (Quarterly) (USD)|Greenwich LifeSciences Inc Non-Operating Interest Expense (Quarterly) (USD)|Greenwich LifeSciences Inc Land and Improvements (Quarterly) (USD)|Greenwich LifeSciences Inc Buildings and Improvements (Quarterly) (USD)|Greenwich LifeSciences Inc Other Properties (Quarterly) (USD)|Greenwich LifeSciences Inc Machine, Furniture & Equipment (Quarterly) (USD)
new_0222_0389|GLSI|Unit|2|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_per_share_metric|percent_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_USD_metric|figure_whole_USD_price|figure_money_USD_per_share_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric
new_0222_0389|GLSI||4|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly
new_0222_0389|GLSI||5|5|106.5|106.5|0|0|106.5|106.5|106.5|106.5|0|106.5|106.5|0|0|0|1.44755244755|0|0|0|1.44571428571|0|0|1.44759206799|0|15.25|0|106.5|106.5|0|0|30.6666666667|30.75|0|30.5|91.4444444444|60.5|91.4444444444|91.4444444444|26.8|0|106.5|0|0|91.4444444444|91.3333333333|0|0|91.3333333333|0|0|0|0|91.4444444444|91.4444444444|91.3333333333|1.44759206799|1.44759206799|1.44759206799|1.45061728395|1.42574257426|15.25|0|0|0|0|0|91.25|0|0|0|91|48.7142857143|52.5|52.5|52.5|52.5|0|0|91.4444444444|91.375|0|0|0|0|0
new_0222_0389|GLSI||6|6|6|6|0|0|6|6|6|6|0|6|6|0|0|0|286|0|0|0|350|0|0|353|0|32|0|6|6|0|0|3|4|0|14|9|2|9|9|15|0|6|0|0|9|6|0|0|6|0|0|0|0|9|9|6|353|353|353|324|101|32|0|0|0|0|0|8|0|0|0|3|7|6|6|6|6|0|0|9|8|0|0|0|0|0
new_0222_0389|GLSI||7|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly
new_0222_0389|GLSI|201906|201906|201906||||||||||||||||||||||||||||||||||11.9702||-0.2175|0.6671||||||-0.2175|||||||||-2.604|-2.604|||||||||||||||||||||||||1.9369||||||
new_0222_0389|GLSI|201909|201909|201909||||||||||||||||||||||||||||||||||11.9702||-0.0281|0.0515||||||-0.0281|||||||||-0.336|-0.336|||||||||||||||||||||||||0.2845|0.0009|||||
new_0222_0389|GLSI|201912|201912|201912|0.0068|0.0068|||0.0198|1.3771|1.3771|0||-1.3524|-27.214|||||||||||||||1.3655|0.0104|||||||11.9702||-0.0281|0.0779|||11.9702|||-0.0281|||||||||-0.3365|-0.3365|||||||||||||||||||||||||0.2587|0.0009|||||
new_0222_0389|GLSI|202003|202003|202003||||||||||||||||||||||||||||||||||11.9702||-0.0204|0.0948||||||-0.0204|0|||-3.5212|||||-0.2446|-0.2446|0||||||||||||||||||||||||0.1499|0.0009|||||
new_0222_0389|GLSI|202006|202006|202006|0.2626|0.0068|||0.018|1.7383|1.7383|0||-1.4596|-27.6691|||||||||||||||1.4021|0.0106|||||||11.9702||-0.0176|0.0596|||11.9702|||-0.0176|0|||-1.1276|||||-0.2104|-0.2104|0||||||||||||||||||||||||0.1508|0.0009|||||
new_0222_0389|GLSI|202009|202009|202009|6.2569|6.2143|||0.0171|1.616|1.616|0||4.6581|-27.9259||||||||11.8209|||0||0.0267||1.4354|0.012|||||||11.9702|3|-0.0215|0.0988|11.9702||11.9702|||-0.0215|-6.2075|||-1.0485|||||-0.2569|-0.2569|0|4.6|4.6|48.8486|||3201||||||||||||||||||0.158|0.0009|||||
new_0222_0389|GLSI|202010|202009|202009|||||||||||||||||||9.0199|||0||0.0154|||||||||||||||||||||||||||||||3.51|3.51|35.8011|||1845||||||||||||||||||||||||
new_0222_0389|GLSI|202011|202009|202009|||||||||||||||||||13.6754|||0||0.0404|||||||||0.0023|||||12.0191|||||||||||||||||5.3|5.3|57.4869|19414.0667||4854||||||||||||||||||||||||
new_0222_0389|GLSI|202012|202012|202012|28.6604|28.6604|||0.0162|1.0455|1.0455|0||27.6311|-29.077||||-376.9736||||16.7672|||0||0.1843||0.9861|0.0127||||||1.1237|12.7035|3|-0.0906|0.553|12.7035||12.7035|||-0.0906|-23.959|||-1.863|||||-1.151|-1.151|0.0008|36.47|36.47|434.6363|1571369.1333||23415||||||0||||0|0|||||||0.5989|0.0009|||||
new_0222_0389|GLSI|202101|202012|202012|||||||||||||||-389.8055||||17.3026|||0||0.3146|||||||||1.1402|||||12.7491|||||||||||||||||37.5|37.5|449.4309|459956.4333||40110|||||||||||0|0|75|1|1|||||||||
new_0222_0389|GLSI|202102|202012|202012|||||||||||||||-321.5795||||14.4558|||0||0.6|||||||||1.2929||||||||||||||||||||||31.33|31.33|370.7689|266294.8667||76500||||||||||||||||||||||||
new_0222_0389|GLSI|202103|202103|202103|30.405|30.405|||0.0153|0.6731|0.6731|0||29.7472|-29.674||||-242.4091||||14.7224|||0||1.4933||0.6093|0.0128||||||3.0269|12.8007||-0.05|0.3186|12.8469||12.8469|||-0.05|-2.548|||-2.2153|||||-0.597|-0.597|0.0036|34.09|34.09|407.5459|593246.3667||191847||||||0||||0||||||||0.282|0.0009|||||
new_0222_0389|GLSI|202104|202103|202103|||||||||||||||-269.2302||||16.2383|||0||0.9567|||||||||2.9465||||||||||||||||||||||37.6|37.6|452.6385|794930.6333||122908|||||||||||0|0|75|1|1|||||||||
new_0222_0389|GLSI|202105|202103|202103|||||||||||||||-266.3352||||16.0747|||0||1.0549|||||||||2.9771|||||12.8958|||||||||||||||||37.08|37.08|447.7713|130892.6||136035||||||||||||||||||||||||
new_0222_0389|GLSI|202106|202106|202106|29.8006|29.8006|||0.0144|0.6526|0.6526|0||29.1625|-30.4237||||-241.0087||||19.9105|||0||1.5048||0.6276|0.0129||||||9.8608|12.8958||-0.06|0.1969|12.9203||12.9203|||-0.06|0|||-2.7546|||||-0.7497|-0.7497|0.0037|44.94|44.94|550.8376|169148.7667||194418||||||0||||0||||||||0.5565|0.0009|||||
new_0222_0389|GLSI|202107|202106|202106|||||||||||||||-210.0866||||17.487|||0||1.587|||||||||12.0092||||||||||||||||||||||39.47|39.47|480.1636|116057.4667||205048||||||||||||||||||||||||
new_0222_0389|GLSI|202108|202106|202106|||||||||||||||-214.052||||17.7978|||0||1.1585|||||||||11.9332|||||12.9692|||||||||||||||||40.02|40.02|489.2268|31260||150254||||||||||||||||||||||||
new_0222_0389|GLSI|202109|202109|202109|28.906|28.906|||0.0135|0.4551|0.4551|0||28.4644|-31.2868||||-150.5426||||17.8349|||0||1.7723||0.2958|0.013||||8.6012||12.4674|12.9689||-0.07|0.2096|12.9936||12.9936|||-0.07|0|||-3.3609|||||-0.8631|-0.8631|0.0036|39.07|39.07|478.754|49214.7|749.3478|230284||||||0||||0|0|0|76.5|1.5|2|||0.6571|0.0009|||||
new_0222_0389|GLSI|202110|202109|202109|||||||||||||||-135.6567||||16.1718|||0||0.8319||||||10|5.0669||11.0814|||||13.0181|||||||||||||||||35.36|35.36|431.414|41536.7667|863.4877|108293|||||||||||0|0|78|2|1|||||||||
new_0222_0389|GLSI|202111|202109|202109|||||||||||||||-120.6099||||14.4907|||0||0.8113||||||10|9.6543||11.1317|||||13.1234|||||||||||||||||31.43|31.43|383.5625|22094.5667|493.0189|106473|||||||||||0|0|78|2|1|||||||||
new_0222_0389|GLSI|202112|202112|202112|||||||||||||||-91.311||||11.2173|||0||0.8174||||||10|-0.1111||11.0165||||||||||||||||||||||24.33|24.33|290.3863|66818.7333|-33.2876|107266||||||0|||||0|0|78|2|1|||||||||
new_0222_0389|GLSI|202201|202112|202112|||||||||||||||-67.1291||||8.5155|||0||1.116||||||3|0.9945||8.1009||||||||||||||||||||||18.47|18.47|213.4832|76266.8667|-50.7467|146455||||||||||||||||||||||||
new_0222_0389|GLSI|202202|202112|202112|||||||||||||||-68.0782||||8.6216|||0|||||||||||||||||||||||||||||||||18.7|18.7|216.5016|74870.0333|-50.6596|||||||||||||||||||||||||
new_0222_0389|GLSI|202203|202203|202203||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||0||||||||||||||||||
new_0222_0389|GLSI|202206|202206|202206||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||0||||||||||||||||||
new_0222_0389|GLSI|202209|202209|202209||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||0||||||||||||||||||
new_0222_0389|GLSI|202212|202212|202212||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||0||||||||||||||||||